Drastic cancer drug price drop to benefit patients


  • Nation
  • Monday, 15 Apr 2019

KUALA LUMPUR: The price of the costly trastuzumab, a breast cancer drug for HER2-positive patients has dropped by more than half in the tender to the Health Ministry, resulting in more patients expected to be treated in the ministry hospitals.

According to industry sources, the originator pharmaceutical company has dropped the price of the drug by about 52% in a tender approved by the ministry after a local drug company brought in a biosimilar version of the drug – the first in Malaysia – that costs about 50% of the original price.

Get 30% off with our ads free Premium Plan

Monthly Plan

RM9.73/month

Annual Plan

RM8.63/month

Billed as RM103.60/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

RM6.5mil in zakat being distributed to over 10,00 recipients in Melaka
Flood victims in Sarawak increases to 356 people
Sabah Tourism Board engages airlines in aviation route development forum
Malaysia strongly condemns Israeli regime's inhumane attack on Palestinians seeking aid in Gaza
25 escooters seized during raid on unlicensed premises in Penang
Yusuf Islam to establish charity organisation in Malaysia
Melaka Civil Defence Force to recruit more professionals to become associate officers
Zambry: Saudi minister committed to increasing scholarships for M'sian students
Agriculture Ministry holds engagement session with padi, rice stakeholders
Missing girl in Inanam found safe

Others Also Read